MedPath
HSA Approval

ROSIDEN INJECTION 20 mg/ml

SIN06575P

ROSIDEN INJECTION 20 mg/ml

ROSIDEN INJECTION 20 mg/ml

September 16, 1991

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAMUSCULAR

Medical Information

M01AC01

piroxicam

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

SHIN POONG PHARMACEUTICAL CO LTD

Active Ingredients

PIROXICAM

20 mg/ml

Piroxicam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ROSIDEN INJECTION 20 mg/ml - HSA Approval | MedPath